Rantak

Rantac is one of the most popular H2 receptor blockers. This drug was developed in India and is manufactured by Unique Pharmaceuticals Laboratory. Rantak is indicated for the treatment of various diseases of the gastrointestinal tract, including gastric ulcers, duodenal ulcers, stress ulcers and exacerbation of peptic ulcers after surgery. Rantac is also used for the prevention and treatment of peptic gastropathy associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs).

The drug is available in the form of tablets of various dosages, available in two packaging options (film-coated and uncoated), which makes it easy to adapt to the required dosage. Should be used strictly following

Abstract on the drug RANTAK

Manufacturer: Unique Laboratories Ltd., India.

Ranitidine belongs to the group of histamine H2 blockers. In terms of its active substance and pharmacological action, it is equivalent to a bromofuran derivative. Blocks the parietal cells of the stomach, reduces the acidity of gastric juice. Suppresses the release of histamine, serotonin and gastrin. It has antisecretory activity and proteolytic activity. It has peripheral, local and central vasoconstrictor effects. Used to treat diseases